...
首页> 外文期刊>Thoracic cancer. >Matrix metalloproteinase‐14 ( MMP ‐14) downregulation inhibits esophageal squamous cell carcinoma cell migration, invasion, and proliferation
【24h】

Matrix metalloproteinase‐14 ( MMP ‐14) downregulation inhibits esophageal squamous cell carcinoma cell migration, invasion, and proliferation

机译:基质金属蛋白酶-14(MMP -14)下调抑制食道鳞状细胞癌细胞迁移,侵袭和增殖

获取原文

摘要

Background: Matrix metalloproteinase-14 (MMP-14) is known to be a key regulator of oncogenesis and tumor progression. The present study was designed to assess the relationship between the downregulation of MMP-14 and the in vitro proliferative, migratory, and invasive activity of esophageal squamous cell carcinoma (ESCC) cells. Methods: MMP-14 expression in human ESCC and paracancerous normal esophageal tissue samples was evaluated via immunohistochemistry, and correlations between MMP-14 staining and patient clinicopathological features were examined. In addition, siRNA was used to knockdown MMP-14 in ESCC cells, and the proliferation and invasive activity of these cells were then evaluated via MTT and Transwell assays, respectively. Flow cytometry was additionally used to assess cell cycle progression, while Western blotting was employed to measure protein levels within these cells. Results: ESCC samples were found to exhibit MMP-14 overexpression relative to paracancerous tissue samples, and this overexpression was positively correlated with tumor T classification (T1-2 vs. T3; P 0.05), N classification (negative vs. positive; P 0.001), degree of differentiation (G1 vs. G3, P 0.05; G2 vs. G3, P 0.05) and clinical stage (I–IIA vs. IIB–III; P 0.05). When MMP-14 was knocked down in ESCC cells, this induced cell cycle arrest, impairing their proliferative and invasive activity. Conclusions: MMP-14 is a key regulator of the proliferation and invasion of ESCC cells, making it a viable therapeutic target for the treatment of this cancer.
机译:背景:已知基质金属蛋白酶-14(MMP-14)是肿瘤发生和肿瘤进展的关键调节剂。本研究旨在评估MMP-14的下调与食管鳞状细胞癌(ESCC)细胞的体外增殖和侵入活性之间的关系。方法:通过免疫组织化学评估人体ESCC和副癌正常食管组织样品MMP-14表达,检查MMP-14染色与患者临床病理学特征之间的相关性。此外,SiRNA用于敲击ESCC细胞中的MMP-14,然后分别通过MTT和Transwell测定评估这些细胞的增殖和侵入活性。流式细胞术另外用于评估细胞周期进展,而Western印迹用于测量这些细胞内的蛋白质水平。结果:发现ESCC样品相对于副癌组织样品表现出MMP-14过表达,并且该过表达与肿瘤T分类呈正相关(T1-2 vs.T3; P <0.05),N分类(负与阳性; P <0.05) <0.001),分化程度(G1与G3,P <0.05; G2 vs.G3,P <0.05)和临床阶段(IIA vs.IIB-III; P <0.05)。当MMP-14在ESCC细胞中撞击时,这种诱导的细胞周期骤停,损害其增殖性和侵袭性活性。结论:MMP-14是ESCC细胞增殖和侵袭的关键调节因子,使其成为治疗该癌症的可行治疗靶标。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号